Therapeutic strategy and prognostic analysis of inflammatory myofibroblastic tumor in the head and neck: a retrospective study
HNIMT is a rare, low-grade malignant or borderline tumor that is generally associated with a favorable prognosis. Accurate diagnosis relies on pathological examination, and surgical resection remains the primary treatment for HNIMT. The need for adjuvant therapy following surgery should be determined by clinicians based on tumor location, surgical approach, and the presence of high-risk factors.
Authors
- Yanchao Qin
- Bowei Feng
- Mengru Li (ORCID: https://orcid.org/0009-0002-6236-1138)
- Zhiwei Zhang (ORCID: https://orcid.org/0000-0003-3338-9385)
- Feng Liu (ORCID: https://orcid.org/0000-0003-1063-4798)
- Wei Ding (ORCID: https://orcid.org/0000-0002-1664-3401)
- Shubin Dong (ORCID: https://orcid.org/0000-0002-2368-4906)
Institutions
- Shanxi Medical University (CN)
- Shanxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-04-18
- DOI
- https://doi.org/10.7717/peerj.19315
- Citations
- 3
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 5.00